Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

Clinical trial NCT05941520 · RECRUITING

Trial details

NCT number: NCT05941520
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Atypical Hyperplasia Breast Carcinoma Breast Ductal Carcinoma In Situ Breast Lobular Carcinoma In Situ

Start date: 2024-10-10
Primary completion: 2027-08-23
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.